Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

neurostatins

- PMLiVE

UPDATE: AZ rejects improved Pfizer bid

Continues to assert independence as Pfizer appeals to Prime Minister David Cameron

Bristol-Myers Squibb (BMS) building

BMS buys Alzheimer’s player iPierian in $725m deal

Takes control of several promising candidates for neurodegenerative diseases

- PMLiVE

CTI launches cancer drug Pixuvri in UK

Now available to treat form of non-Hodgkin lymphoma

UK flag

Boost for UK bioscience as MedCity launches

London Mayor Boris Johnson declares ‘golden trial’ of medical research

UK flag

UK gets its own ‘breakthrough’ status for early medicines access

But concerns remain over funding

Biogen Idec building

Eisai and Biogen partner on Alzheimer’s

Will co-develop two drug candidates

- PMLiVE

Novartis to close UK R&D site

Research operations at Horsham expected to end in June

UK flag

UK plans to reduce use of animals in research

Looks to new technologies to screen earlier for drug failures

- PMLiVE

Salix Consulting launches UK pharmacy campaign

'Dispensing Health' aims to shift perceptions about community pharmacy

- PMLiVE

Pharma slammed by MPs for withholding trial data

Follows damning Tamiflu and data access report from UK's Public Accounts Committee

- PMLiVE

Skills in healthcare: pharmacy challenges in the UK

The challenges today’s pharmacists face

- PMLiVE

J&J extends partnering network in UK

Will open offices in life sciences ‘hotspots’

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links